1. Identification of HIPK3 as a potential biomarker and an inhibitor of clear cell renal cell carcinoma
   Wen Xiao et al, 2021, Aging CrossRef
2. Regulation of anoikis by extrinsic death receptor pathways
   Ying-Hao Han et al, 2023, Cell Communication and Signaling CrossRef
3. Anoikis Resistance and Tumor Metastasis
   Zhuqian Wang et al, 2023, Handbook of Cancer and Immunology CrossRef
4. Tetraiodothyroacetic acid and transthyretin silencing inhibit pro-metastatic effect of L-thyroxin in anoikis-resistant prostate cancer cells through regulation of MAPK/ERK pathway
   Peng Zhang et al, 2016, Experimental Cell Research CrossRef
5. Alpha-mangostin, an active compound in Garcinia mangostana, abrogates anoikis-resistance in human hepatocellular carcinoma cells
   Benjawan Wudtiwai et al, 2018, Toxicology in Vitro CrossRef
6. Role of Tropomyosin-related kinase B receptor and brain-derived neurotrophic factor in cancer
   Vilson Serafim Junior et al, 2020, Cytokine CrossRef
7. New frontiers against sorafenib resistance in renal cell carcinoma: From molecular mechanisms to predictive biomarkers
   Yu He et al, 2021, Pharmacological Research CrossRef
8. Establishment and validation of a novel anoikis-related prognostic signature of clear cell renal cell carcinoma
   Yankuo Liu et al, 2023, Frontiers in Immunology CrossRef
9. Comprehensive analysis of anoikis‐related lncRNAs for predicting prognosis and response of immunotherapy in hepatocellular carcinoma
   Sihao Du et al, 2023, IET Systems Biology CrossRef
10. Crosstalk between VEGFR and other receptor tyrosine kinases for TKI therapy of metastatic renal cell carcinoma
    Yongchang Lai et al, 2018, Cancer Cell International CrossRef
11. Erlotinib inhibits colon cancer metastasis through inactivation of TrkB‐dependent ERK signaling pathway
    Tao Shen et al, 2019, Journal of Cellular Biochemistry CrossRef
12. Tumor-induced neoangiogenesis and receptor tyrosine kinases – Mechanisms and strategies for acquired resistance
    Madiha Yunus et al, 2019, Biochimica et Biophysica Acta (BBA) - General Subjects CrossRef
13. AMPK/GSK3β/β‐catenin cascade‐triggered overexpression of CEMIP promotes migration and invasion in anoikis‐resistant prostate cancer cells by enhancing metabolic reprogramming
    Peng Zhang et al, 2018, The FASEB Journal CrossRef
14. High Expression of DNTTIP1 Predicts Poor Prognosis in Clear Cell Renal Cell Carcinoma
    Xuegang Wang et al, 2023, Pharmacogenomics and Personalized Medicine CrossRef
15. Dual inhibition of BDNF/TrkB and autophagy: a promising therapeutic approach for colorectal cancer
    Clément Mazouffre et al, 2017, Journal of Cellular and Molecular Medicine CrossRef
16. Neurotrophin Signaling in Medulloblastoma
    Amanda Thomaz et al, 2020, Cancers CrossRef
17. Mechanisms for Modulating Anoikis Resistance in Cancer and the Relevance of Metabolic Reprogramming
    Funmilayo O. Adeshakin et al, 2021, Frontiers in Oncology CrossRef
18. Cell death under epithelial–mesenchymal transition control in prostate cancer therapeutic response
    Diane Begemann et al, 2018, International Journal of Urology CrossRef
19. Anoikis-related lncRNA signature predicts prognosis and is associated with immune infiltration in hepatocellular carcinoma
    Jiahong Zhu et al, 2024, Anti-Cancer Drugs CrossRef